Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03700294
Title Safety, Tolerability, Pharmacokinetics, and Antitumor Study of ADCT-601 to Treat Advanced Solid Tumors
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors ADC Therapeutics S.A.
Indications

sarcoma

nasopharynx carcinoma

malignant mesothelioma

colorectal cancer

ovarian cancer

lung non-small cell carcinoma

stomach cancer

head and neck squamous cell carcinoma

pancreatic cancer

esophageal cancer

triple-receptor negative breast cancer

Therapies

ADCT-601

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Sarah Cannon Research Institute at HealthONE Denver Colorado 80218 United States Details
Florida Cancer Specialists Sarasota Florida 34232 United States Details
The Sarah Cannon Research Institute (Tennessee Oncology) Nashville Tennessee 37203 United States Details
NEXT Oncology San Antonio Texas 78240 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field